BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 8547219)

  • 1. Induction of apoptosis in p53-deficient human hepatoma cell line by wild-type p53 gene transduction: inhibition by antioxidant.
    Lee KH; Kim KC; Jung YJ; Ham YH; Jang JJ; Kwon H; Sung YC; Kim SH; Han SK; Kim CM
    Mol Cells; 2001 Aug; 12(1):17-24. PubMed ID: 11561726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner.
    Potapova O; Gorospe M; Dougherty RH; Dean NM; Gaarde WA; Holbrook NJ
    Mol Cell Biol; 2000 Mar; 20(5):1713-22. PubMed ID: 10669748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between expression of p21WAF1/CIP1 and radioresistance in human gliomas.
    Kokunai T; Tamaki N
    Jpn J Cancer Res; 1999 Jun; 90(6):638-46. PubMed ID: 10429656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and the CNS: tumors and developmental abnormalities.
    Fulci G; Van Meir EG
    Mol Neurobiol; 1999 Feb; 19(1):61-77. PubMed ID: 10321972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and brain tumors: from gene mutations to gene therapy.
    Fulci G; Ishii N; Van Meir EG
    Brain Pathol; 1998 Oct; 8(4):599-613. PubMed ID: 9804370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Cell Cycle Regulators in Cell Survival-Dual Functions of Cyclin-Dependent Kinase 20 and p21
    Lai L; Shin GY; Qiu H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
    Zhang W; Grasso L; McClain CD; Gambel AM; Cha Y; Travali S; Deisseroth AB; Mercer WE
    Cancer Res; 1995 Feb; 55(3):668-74. PubMed ID: 7834638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
    Ozçelik H; Mousses S; Andrulis IL
    Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
    Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
    Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel approach for cancer chemoprevention referred to as "gene-regulating chemoprevention"].
    Nakano K; Yamagishi H; Oka T; Sakai T
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):373-8. PubMed ID: 9695075
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.